ABSTRACT Cerebellitis is a rarely encountered complication of isoniazid therapy. Its occurrence is usually associated with concomitant renal disease and haemodialysis. Herein, we report the case of a patient with this complication who presented with isolated bilateral symmetrical dentate nucleus T2 hyperintensities on magnetic resonance imaging. Isoniazid neurotoxicity has never been reported to cause bilateral dentate hyperintensities, for which the differentials are few and include metronidazole toxicity.
I NTRO D U C TIO N
Chronic kidney disease (CKD) and tuberculosis have been proven to be interrelated. An increased incidence of tuberculosis, as well as side effects of antituberculosis therapy, has been reported in patients with CKD, especially in those on haemodialysis.
(1) Although the neurotoxic complications of isoniazid (INH) are well known, cerebellitis is rarely reported as one of them.
(1-3)
Our patient was a middle-aged woman who presented with vertigo following the initiation of antituberculosis therapy.
On investigation, the patient was diagnosed to have CKD, and INH neurotoxic complications were diagnosed through a process of exclusion. Dramatic improvement was observed with the discontinuation of INH and supplementation with highdose pyridoxine. Magnetic resonance (MR) imaging findings of isolated bilateral dentate nucleus signal alteration were unusual, as INH neurotoxicity is generally not included in the differential diagnosis of this presentation. Other investigations, including cerebrospinal fluid (CSF) analysis, were normal. In view of the repeated attacks of dizziness, the patient underwent MR imaging of the brain, which revealed bilateral symmetrical dentate nucleus hyperintensities on T2-weighted ( Fig. 1 ) and T2 fluid-attenuated inversion recovery (FLAIR) images (Fig. 2) . The dentate nuclei appeared isointense on T1-weighted images and showed no evidence of restricted diffusion on diffusion-weighted imaging (Fig. 3) . No other areas of signal alteration were noted in the bilateral cerebral or and the patient was started on high-dose pyridoxine (100 mg/ day). The patient experienced dramatic improvement in her symptoms, further confirming the diagnosis. She was subsequently discharged on daily pyridoxine supplementation, and a followup session was scheduled one month later. At follow-up, the patient remained asymptomatic. Repeat MR imaging of the brain six weeks post discharge showed complete resolution of the bilaleral dentate nucleus hyperintensities (Fig. 4) .
CA S E R EPO RT
A
D I SCU S S IO N
A diagnosis of drug toxicity is made primarily through a process of exclusion. To make such a diagnosis, it is important to demonstrate a close association between the onset of drug usage and the onset of symptoms, as was evidenced in our 
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Another particularly interesting aspect of our patient was the finding of isolated bilateral symmetrical dentate nucleus hyperintensities on T2-weighted and T2 FLAIR MR imaging. As acute cerebellitis usually presents with diffuse signal alterations throughout the bilateral cerebellar hemispheres, (5) the isolated involvement of the dentate nuclei in our patient was unusual.
Only few pathologies are included in the differential diagnoses of bilateral dentate nuclei hyperintensities on T2-weighted MR images. These include methyl bromide intoxication, enteroviral encephalopathies, maple syrup urine disease and metronidazole toxicity. (6, 7) Bilateral dentate involvement has also been described as part of the atypical presentation of Wernicke encephalopathy, (8) although not in isolation. In the present case, all these differentials were ruled out based on the patient's medical history and the results of clinical investigations (including CSF analysis). Therefore, by a process of exclusion, we concluded that the unusual imaging presentations seen in our patient were a result of INH neurotoxicity.
In conclusion, the possibility of cerebellitis secondary to INH neurotoxicity should be considered in patients with CKD who present with neurological complaints after starting antituberculosis therapy. As a preventive strategy, treatment with high-dose pyridoxine should be initiated for patients with known CKD who are being started on antituberculosis therapy.
INH should also be withheld if symptoms of neurotoxicity develop. INH-induced neurotoxicity should be included in the differential diagnosis of bilateral symmetrical dentate nucleus hyperintensities on T2-weighted or T2 FLAIR MR images.
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